Table 2.
Drugs | H.c. McM | H.c. CAVR | RR | p | T.c. McM | T.c. MOX-R | RR | p | O.c. McM | O.c. WAMIRO | RR | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | |||||||
B1a | 502 (360–699) | 621 (425.5–906.7) | 1.24 | 595 (407–868.6) | 1070 (715.8–1602) | 1.79 | ⁎ | 472 (288.5–773.4) | 1820 (1280–2600) | 3.86 | ⁎⁎ | |
B1b | 652 (387.2–1098) | 873 (636.6–1198) | 1.34 | 535 (351.6–814.9) | 3780 (2429–5878) | 7.07 | ⁎⁎ | 514 (337.6–783.6) | 833 (643.1–1095) | 1.62 | ⁎ | |
IVM | 676 (402.3–1136) | 755 (338.4–1683) | 1.12 | 447 (309.8–643.7) | 1420 (933.0–2152) | 3.18 | ⁎⁎ | 266 (197.7–357.4) | 1130 (744.3–1724) | 4.25 | ⁎⁎ | |
MOX | 371 (301.6–456.4) | 2500 (1530–4070) | 6.74 | ⁎⁎ | 471 (326.8–678.4) | 3430 (3323–5332) | 7.28 | ⁎⁎ | 618 (485.2–788.2) | 13900 (6112–31590) | 22.45 | ⁎⁎ |
Mil A3 | 1970 (1199–3225) | 670 (461.1–973.6) | n.c. | 803 (507.7–1271) | 2550 (1857–3498) | 3.18 | ⁎⁎ | 1240 (921.3–1667) | 7870 (4003–15480) | 6.35 | ⁎⁎ | |
Mil A4 | 827 (522.8–1308) | 792 (498.7–1257) | n.c. | 1200 (753.4–1909) | 9870 (6254–15560) | 8.23 | ⁎⁎ | 1410 (817–2441) | 2510 (1519–4136) | 1.78 |
n.c. = not calculated.
p < 0.0001;
p < 0.05.